Risk factor
Resilient to price shocks
Profitability factor
Favourable price performance
About
Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye...
Company Valuation
Based on key historical and expected multiples, the stock is fairly valued relative to its peers. Specifically, the stock is 'expensive' on P/E, neutral on EV/EBITDA, und
Target Price
The average target price of BLCO is 17 and suggests 11% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation su
Buy
Sell